LONGITUDINAL TRENDS IN RENAL FUNCTION IN CHRONIC HEPATITIS B PATIENTS RECEIVING NUCLEOS(T)IDE ANALOGUES

被引:0
|
作者
Kim, Donghee
Kim, W. Ray
Udompap, Prowpanga
Ahmed, Aijaz
机构
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Sa1498
引用
收藏
页码:S1133 / S1133
页数:1
相关论文
共 50 条
  • [21] Benefit of stopping finite nucleos(t)ide analogues therapy in chronic hepatitis B patients
    Liaw, Yun-Fan
    Jeng, Wen-Juei
    GUT, 2020, 69 (10) : 1898 - 1899
  • [22] Recent data on treatment of chronic hepatitis B with nucleos(t)ide analogues
    Leung, Nancy
    HEPATOLOGY INTERNATIONAL, 2008, 2 (02) : 163 - 178
  • [23] Peginterferon for the treatment of chronic hepatitis B in the era of nucleos(t)ide analogues
    Buster, Erik H. C. J.
    Schalm, Solko W.
    Janssen, Harry L. A.
    BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2008, 22 (06) : 1093 - 1108
  • [24] Treatment of HBeAg-negative chronic hepatitis B patients with nucleos(t)ide analogues
    Papatheodoridis, George V.
    LIVER INTERNATIONAL, 2011, 31 : 95 - 103
  • [25] Economic Evaluation of Oral Nucleos(t)ide Analogues for Patients with Chronic Hepatitis B in Thailand
    Dilokthornsakul, Piyameth
    Sawangjit, Ratree
    Tangkijvanich, Pisit
    Chayanupatkul, Maneerat
    Tanwandee, Tawesak
    Sukeepaisarnjaroen, Wattana
    Sriuttha, Pajaree
    Permsuwan, Unchalee
    APPLIED HEALTH ECONOMICS AND HEALTH POLICY, 2022, 20 (04) : 587 - 596
  • [26] Management of Virologic Failure in Patients with Chronic Hepatitis B Treated with Nucleos(t)ide Analogues
    Tafesh Z.H.
    Brown R.S., Jr.
    Current Hepatology Reports, 2019, 18 (3) : 363 - 369
  • [27] Economic Evaluation of Oral Nucleos(t)ide Analogues for Patients with Chronic Hepatitis B in Thailand
    Piyameth Dilokthornsakul
    Ratree Sawangjit
    Pisit Tangkijvanich
    Maneerat Chayanupatkul
    Tawesak Tanwandee
    Wattana Sukeepaisarnjaroen
    Pajaree Sriuttha
    Unchalee Permsuwan
    Applied Health Economics and Health Policy, 2022, 20 : 587 - 596
  • [28] Cessation of nucleos(t)ide analogues for patients with chronic hepatitis B in Taiwan: Risky but inevitable
    Lee, I-Cheng
    Huang, Yi-Hsiang
    JOURNAL OF THE CHINESE MEDICAL ASSOCIATION, 2020, 83 (06) : 515 - 516
  • [29] Clinical-features analysis on 926 patients with virological breakthrough in chronic hepatitis B receiving nucleos(t)ide analogues
    Huang, Cheng
    Yang, Xiang-hui
    Yang, You-lan
    Huang, Ai-long
    Shi, Xiao-Feng
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2018, 53 : E9 - E10
  • [30] Prevalence of Potential Resistance Related Variants Among Chinese Chronic Hepatitis B Patients Not Receiving Nucleos(T)ide Analogues
    Qian, Fuchu
    Zou, Weihua
    Jin, Fang
    Li, Dongli
    Shen, Yujuan
    INFECTION AND DRUG RESISTANCE, 2020, 13 : 2407 - 2416